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1. Introduction  
The Central African region, also called Atlantic Equatorial Africa, harbors one of the biggest 
worldwide biodiversity. It is true for human, with a great diversity of ethnic groups, but 
also for animals, plants, and microorganisms including pathogen species. Although this 
region is lagging behind in various domains, few research centers and laboratories have 
been able to develop sophisticated research work for diagnostics, fundamental research, and 
operational research, using polymerase chain reaction (PCR) techniques. This present paper 
intends to give an overview of the use of PCR technology in Central Africa and its various 
applications in the field of genetics, phylogeography, ecology, botany, and infectious 
diseases, which may have a broad impact on interspecies relationships, diagnostics of 
diseases, environment and biodiversity. 
We will successively describe the main research findings in humans, animals, plants and 
pathogens from Central Africa, and show how the PCR has allowed scientists from this 
region to contribute significantly to generalized knowledge in these fields. Then, we’ll 
discuss opportunities and challenges in conducting such kind of research in these particular 
limited-resources settings before concluding this chapter. 
2. Humans 
Since the nineties, the extensive use of molecular techniques has contributed to deepen the 
knowledge on human genetics. In most studies related to Central Africa, such 
www.intechopen.com
 
Polymerase Chain Reaction 
 
310 
methodologies have often been used in the context of immunogenetics or genetic 
epidemiology of infectious diseases. The host genetic background is as important as 
immunity in the individual fight against infections. These studies were a fabulous 
opportunity to investigate the richness and extreme diversity of the genetic polymorphisms 
that characterize populations from Central Africa. 
2.1 HLA characterization 
The major histocompatibility complex (MHC) is one of the most polymorphic genetic 
systems of many species, including human leukocyte antigen (HLA) in humans. The class I 
and class II MHC genes encode cell-surface heterodimers that play an important role in 
antigen presentation, tolerance, and self/non-self recognition. The HLA molecules bind 
intracellularly processed antigenic peptides, forming complexes that are the ligands of the 
antigen receptors of T lymphocytes. In addition, the class I and class II histocompatibility 
antigens play an important role in allogeneic transplantation. Matching for the alleles at the 
class I and class II MHC loci impacts the outcome of both solid-organ and hematopoietic 
stem cell allogeneic transplants. 
The HLA class II typing of 167 unrelated Gabonese individuals living in the village of Dienga, 
located in the South-East of Gabon (province of the Haut-Ogooué) was assessed by 
polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) [2]. All 
individuals belonged to the Banzabi ethnic group, which represents the second most 
important population grouping in Gabon after the Fang, with 55,000 to 60,000 individuals 
living in an area of 32,000 km2. At the date of realization, in 1996, restriction endonuclease 
mapping of the PCR products provided profiles that allowed identification of 135 major alleles 
or groups of alleles among the 184 known DRB1 alleles [3]. Similarly, 9, 24 and 53 major alleles 
or groups of alleles were recognizable out of a total of 19, 35 and 83 DQA1, DQB1 and DPB1 
alleles respectively, so far reported in the literature. For each locus, the PCR-RFLP identified 
alleles include all major alleles, while unidentifiable alleles were corresponding to rare and 
newly described alleles. The most frequent alleles at each locus were DRB1*1501–3 (0.31), 
DQA1*0102 (0.50), DQB1*0602 (0.42) and DPB1*0402 (0.29). The estimation of the haplotype 
frequencies as well as the observation of the segregation of several haplotypes using additional 
HLA typing of relatives, revealed that the three-locus haplotype DRB1*1501–3-DQA1*0102-
DQB1*0602 was found at the highest frequency (0.31) among these individuals. This haplotype 
is not typically African and has already been described in Caucasians, but its presence at high 
frequency is exclusive to populations originating from Central Africa, and can thus be 
designated as a particular genetic marker of these populations. On the other hand, the absence 
in the Gabonese Banzabi group of DRB1*04 and the concomitant predominance at equal 
prevalence rates of DRB1*02 and DRB1*05, conforms to the other sub-Saharan population 
groups which have already been typed for their DR1-DR10 allospecificities [4]. Similarly, the 
predominant alleles observed at the DQA1, DQB1 and DPB1 loci studied have already been 
described in other sub-Saharan populations [5]. As an example, the determination of DRB1-
DQA1-DQB1 haplotype frequencies for 230 Gabonese individuals belonging to tribes as 
different as Fang, Kele, Myene, Punu, Sira and Tsogo, revealed, as for the Banzabi group, the 
highest frequency (0.24) for the DRB1*15/16-DQA1*0102-DQB1*0602 haplotype [6]. The same 
predominant haplotype was observed with a high frequency of 0.27 among 126 healthy 
individuals in Cameroon, by means of a determination by high-resolution PCR using 
sequence-specific oligonucleotide probes (PCR-SSOP) and/or DNA sequencing [7]. 
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Few studies investigated the extensive allelic diversity in the class I loci (to date, more than 
250 HLA-A, 500 HLA-B, and 120 HLA-C alleles) by means of molecular methods among 
populations of Central Africa [5]. In populations as geographically close as Cameroonians 
(Yaoundé) [8] and Gabonese (Dienga, South-East of Gabon) [9], the two most frequently 
detected HLA-A and HLA-B allele families diverged, illustrating the patchwork representation 
of the different genetic backgrounds (Cameroon: HLA-A*23, A*29, HLA-B*53 and B*58; 
Gabon: HLA-A*19, A*10, HLA-B*17 and B*70). In Cameroon, where populations are very 
heterogeneous in their origin, culture and language, the most frequently encountered HLA-A, 
HLA-B and HLA-C alleles differed in four ethnic groups distributed from the north to the 
south of the country, reflecting the complex migrations and admixtures that occurred in this 
area located in the borders of Central and west Africa, before that populations settled [10]. 
2.2 Red blood cell polymorphisms 
Red blood cell polymorphisms are frequently found in areas where malaria is currently or 
was historically endemic. This observation led to the idea that some of these polymorphisms 
might provide a relative advantage for survival [11]. The best-characterized polymorphism 
in this context is the sickle cell trait (HbAS), comprising heterozygous carriage of 
hemoglobin (Hb) S, which results from a valine substitution for glutamic acid at position 6 
of the hemoglobin β chain. HbAS provides carriers with a high degree of protection against 
severe Plasmodium falciparum malaria during early life, which explains the relatively high 
penetrance of this mutation— in some areas reaching 30%—in sub-Saharan African 
communities exposed to high rates of infection with P. falciparum [12]. The mutation in the 
homozygous state (HbSS) leads to the disease referred to as “sickle cell anemia,” a life-
threatening condition that usually results in early death [13, 14]. HbAS in such populations 
thus exemplifies a balanced polymorphism that confers a selective advantage to the 
heterozygote [15]. Molecular determination of the HbS carriage is assessed by PCR-RFLP, 
where a 369-bp segment of the codon 6 in the beta-globine gene, encompassing the A>T 
substitution, is amplified, before being digested with the restriction endonuclease DdeI. 
In sub-Saharan populations, the ABO blood group distribution is in large part dominated by 
the O blood group, with prevalence rates of at least 50%. Strong hypotheses favor a selection 
pressure exerted by the plasmodial parasite on its host cell, and include i) the worldwide 
distribution of the ABO blood groups with a type O predominance in malarious regions of 
the world [16], ii) the fact that Plasmodium falciparum has substantially affected the human 
genome and was present when the ABO polymorphisms arose [17], iii) the associations of 
ABO blood groups and clinical outcome of malaria with the observation of a degree of 
protection conferred by blood group O against severe courses of the disease [18] and iv) the 
potential role that erythrocyte surface antigens may play in cytoadhesion of infected 
erythrocytes to micro vessel endothelia and in parasite invasion [19]. No molecular method 
is used for the determination of ABO blood groups, as hematological methods (Beth-Vincent 
and Simonin techniques) are both simple and robust.  
G6PD is a cytoplasmic enzyme allowing cells to withstand oxidant stress. It is encoded by 
one of the most polymorphic genes in humans, located on the X chromosome. In Africa, 
G6PD is represented by three major variants, G6PD B (normal), G6PD A (90% enzyme activity) 
and G6PD A- (12% enzyme activity) [20]. The location of the G6PD gene on the X chromosome 
and the subsequent variable X-chromosome inactivation implies that the expression of G6PD 
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deficiency differs markedly among heterozygous females and therefore that these females do 
not constitute a homogeneous group [21]. PCR-RFLP is used for the molecular determination 
of the predominant G6PD A- variant in sub-Saharan Africa: mutation 376 A>G responsible for 
the G6PD A electrophoretic mobility and mutation 202 G>A responsible for the A- deficiency, 
are determined by PCR amplification of exons 5 and 4 respectively, followed by restriction 
enzyme analysis, using FokI (376 A>G mutation) and NlaIII (202 G>A mutation). However, the 
376 A>G mutation may also be associated with other deleterious mutations such as 542 A>T 
(G6PD Santamaria), 680 G>T or 968 T>C, revealed after electrophoretic migration of digested 
amplified products with BspEI, BstNI and NciI respectively. 
Table 1 presents data obtained among healthy individuals in order to avoid distribution bias 
due to selection of genetic traits by secularly settled diseases such as malaria. No HbSS 
individual was recorded in the studies gathered in this Table, because of an age range 
beyond the life expectancy of most HbSS patients in developing countries. Since the G6PD A 
and B variants have almost the same enzyme activity, the patients were stratified into 
groups with normal (female BB, AB, AA and male B and A genotypes), heterozygous 
(female A-B and A-A genotypes) and homo-/hemi-zygous (female A-A- and male A- 
genotypes) state, corresponding to decreasing levels of G6PD enzymatic activity. Some 
research teams have extensively studied erythrocyte polymorphisms in relation to malaria 
morbidity, among children hospitalized at the Albert Schweitzer Hospital from Lambaréné, 
in the Moyen Ogooué province of Gabon. As these genetic traits strongly influence the 
distribution of the clinical pattern of malaria, their frequency distribution is not 
representative of the whole population, and therefore they could not be reported in Table 1. 
 
Erythrocyte 
polymorphisms 
Prevalence rate (%) 
 Gabon 
(Dienga) 
Cameroun 
(Ebolowa) 
Republic of Congo 
(Brazzaville) 
ABO blood groups: 
Group O 
Group A 
Group B 
Group AB 
N = 279         [22] [23] 
54 
27 
17 
2 
N = 1,007         [24]
51 
24 
19 
6 
N = 13,045         [27] 
53 
22 
21 
4 
HbS genotypes: 
Hb AA 
Hb AS 
Hb SS 
N = 279         [22] [23] 
77 
23 
0 
N = 240           [25]
81 
19 
0 
N = 868             [28] 
80 
20 
0 
G6PD state: 
- Normal (genotypes 
BB, AB, AA, B & A) 
- Heterozygous 
(genotypes A-B & A-A)
- Homo-/hemi-zygous 
(genotypes A-A- & A-) 
N = 271 M & F [22] [23]
78 
 
13 
 
9 
N = 561 M       [26]
93 
 
0 
 
7 
N = 398 M & F   [29] 
68 
 
21 
 
11 
M: males; F: females. 
Table 1. Erythrocyte polymorphisms among healthy individuals from Central Africa 
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Other erythrocyte polymorphisms characterize the sub-Saharan populations, including 
Central Africans. It is the case of the alpha-thalassemia, which consists in the deletion of 1, 2, 
3 or the 4 genes encoding the alpha chain of the globin. Several forms of alpha-thalassemia 
are distributed worldwide, and the form encountered in sub-Saharan Africa resides in a 
gene deletion of 3.7 kb (-α3.7 type), which generates the formation of a functional hybrid 
gene. A PCR amplification strategy using three primers allows to determine the normal 
(αα/αα), heterozygous (-α3.7 /αα) and homozygous (-α3.7/-α3.7) state as well as the - -/-α3.7 
form (H haemoglobin) [30]. The prevalence of α+-thalassemia in Africa ranges from 5 to 
50%, according to a gradient from North Africa to equatorial Africa and from South Africa 
to equatorial Africa: so, the highest prevalence rates are reached in the Central African 
Republic [31] and in a Bantu population from the republic of Congo [32]. Different 
erythrocyte polymorphisms may coexist in the same individual, as the results of 
advantageous interactions. Namely, a beneficial effect of α+-thalassemia on the 
hematological characteristics of sickle-cell anemia patients has been found, in accordance 
with the observation in HbAS individuals of decreasing values of HbS quantification 
accompanying decreasing numbers of α-globin genes (from 4 to 2) [32]. 
2.3 Innate immunity 
For the needs of malaria-linked studies, polymorphisms of some products of the inflammatory 
response have been investigated among populations from Central African countries.  
Mannose binding lectin (MBL) is a member of the collectin family of proteins, which are 
components of the innate immune system, acting therefore against multiple pathogenic 
organisms. MBL is thought to be more effective at an early age, before effective acquired 
immune responses have developed, and low plasma concentrations of non-functional MBL 
have been attributed to mutations in the first exon of the MBL gene: MBLIVS-I-5 G>A, MBL54 
G>A and MBL57 G>A. PCR-RFLP determination may be performed, using NlaIII (codon 52), 
BanI (codon 54) and MboII (codon 57) endonucleases. At least one MBP gene mutation was 
present in 34% of a Gabonese population sample (Banzabi), with an overall gene frequency 
of 0.03, 0.02 and 0.18 mutations at codons 52, 54 and 57, respectively [22, 25]. There are other 
published MBL2 genotyping techniques, based on sequence-specific PCR, denaturing 
gradient gel electrophoresis of PCR-amplified fragments, real-time PCR with the 
hybridization of sequence-specific probes and sequence-based typing. A new strategy that 
combines sequence-specific PCR and sequence-based typing (Haplotype Specific 
Sequencing or HSS) was recently improved and allowed identification of 14 MBL allele-
specific fragments (located in the promoter and exon 1) among Gabonese individuals [33].  
Inducible nitric oxide synthase 2 (NOS2) is the critical enzyme involved in the synthesis of 
nitric oxide, a short-lived molecule with diverse functions including antimalarial activity, that 
can also cause damage to the host cell. The most investigated polymorphism is located in the 
promoter region of NOS2, and concerns the point mutation NOS2-954 G>C, which is associated 
with an increased production of NOS2. By the means of a PCR amplification followed by 
enzymatic digestion with BsaI, this point mutation was found in 18% of Gabonese individuals 
from the Banzabi ethnic group, mainly in the heterozygous state [22, 25]. A similar high 
prevalence was found in another Gabonese population group, recruited in Lambaréné [34]. 
Tumor necrosis factor α (TNF-α) is a proinflammatory cytokine that provides rapid host 
defense against infection but is detrimental or fatal in excess. The main studied 
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polymorphisms are located in the promoter region of the gene and are TNFα-308 G>A and 
TNFα-238 G>A base substitutions. These two polymorphisms have not been related to any 
variation in cytokine production, but may serve as markers for a functional polymorphism 
elsewhere in the TNF-α gene. Indeed, the TNFα376 A allele (G>A substitution), which is 
frequently found in linkage disequilibrium with TNFα-238 A allele, is related to enhanced 
secretion of TNF and might be responsible for increased antigen- or T-cell mediated B-cell 
stimulation and proliferation [35]. Molecular determination is assessed by PCR-RFLP using 
NcoI (-308), AlwI (-238) and FokI (376) restriction endonucleases. Prevalence rates of 22% 
(TNFα-308 A allele) and 17% (TNFα-238 A allele) were found in a Gabonese population 
(Banzabi), mainly in the heterozygous state [22, 25]. 
Haptoglobin (Hp) is an acute-phase protein that binds irreversibly to hemoglobin (Hb), 
enabling its safe and rapid clearance. Therefore, Hp has an important protective role in 
hemolytic disease because it greatly reduces the oxidative and peroxidative potential of free 
Hb. Haptoglobin exists in three phenotypic forms: Hp1-1, 2-1, and 2-2, which are encoded 
by two co-dominant alleles, Hp1 and Hp2. A fourth phenotype HpO, referred to as hypo- or 
an-haptoglobinaemia has been reported to be the predominant phenotype in West Africa. 
Functional differences between the different Hp phenotypes have been reported, the ability 
to bind Hb being in the order of 1-1 > 2-1 > 2-2. The gene frequencies of different Hp 
phenotypes show marked geographical differences as well as large variations among 
different ethnic groups. Hp genotypes determined by PCR in 511 Gabonese children from the 
village of Bakoumba (South-East of Gabon), distributed into 36.5%, 47.6% and 15.9% for Hp1-
1, Hp2-1 and Hp2-2 respectively [36]. In South-West Cameroon, the genotype distribution 
among 98 pregnant women was 53% for Hp1-1, 22% for Hp2-1 and 25% for Hp2-2 [37].  
2.4 Polymorphism of the cytochrome P450 superfamily 
The DNA samples of the Gabonese individuals from the Banzabi ethnic group already 
described [2] entered a dataset of DNA samples from European (French Caucasians), African 
(Senegalese), South American (Peruvians) and North African (Tunisians) populations, in order 
to evaluate the inter-ethnic variations in the genetic polymorphism of several components of 
the cytochrome P450 superfamily (CYP) which gathers a large and diverse group of enzymes 
(Table 2). The function of most CYP enzymes is to catalyze the oxidation of organic substances. 
Their substrates include metabolic intermediates such as lipids and steroidal hormones, as 
well as xenobiotic substances such as drugs and other toxic chemicals. The investigation of the 
variable number of tandem repeat (VNTR) polymorphism of the human prostacyclin synthase 
gene (CYP8A1) revealed a particular distribution of the nine characterized alleles in the 
Gabonese population group, which may be associated with a more frequent and severe form 
of hypertension found in some Black populations [38]. The frequencies of three single 
nucleotide polymorphisms occurring in the CYP2A13 were determined by PCR-single strand 
conformational polymorphism (PCR-SSCP) (578C>T (Arg101Stop)) and PCR-RFLP (3375C>T 
(Arg257Cys) and 720C>G (3’-untranslated region)) and were respectively 0, 15.3 and 20.8 
among the Gabonese group, differing from those of other groups under comparison: these 
marked inter-ethnic variations in an enzyme involved in the metabolism of compounds 
provided by the use of tobacco, have consequences on the susceptibility to lung cancer [39]. 
More precisely, it appears that black populations could present a higher deficit in CYP2A13 
activity compared with other population groups, compatible with a reduced risk for smoking-
related lung adenocarcinoma. In the same way, a frameshift mutation, responsible for the 
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synthesis of a truncated protein of the CYP2F1, which activity in lung tissue is linked to 
carcinogenic effects, was mostly represented in the Gabonese population sample [40]. The 
genetic polymorphism of the CYP3A5 enzyme, implicated in the metabolism of 
chemotherapeutic agents but also toxins, was analyzed using a PCR-SSCP strategy, leading to 
the observation of great inter-ethnic differences in the distribution of a maximum of 17 alleles, 
some of them being linked to the synthesis of a non functional enzyme. According to the 
determination of the CYP3A5 predicted phenotype, Gabonese individuals were the most 
numerous (90.0%) to express a complete and functional CYP3A5 protein compared to French 
Caucasians (10.4%) and Tunisians (30.0%) [41]. The CYP4A11 enzyme is involved in the 
regulation of the blood pressure in the kidney, and an 8590T>C mutation has been associated 
to an increased prevalence of hypertension. Using PCR-SSCP and nucleotide sequence 
analysis, the frequency of this mutation was found lower in Gabonese compared to other 
investigated African population groups (Tunisians, Senegalese) [42]. Lastly, 3 single nucleotide 
polymorphisms (SNPs) affecting the human type II inosine monophosphate dehydrogenase 
(IMPDH2) gene have been determined by PCR-SSCP. This enzyme participates in the 
metabolism of purines and constitutes a target for antiviral drugs. It resulted that African 
 
P450 
Tissue 
location 
Clinical 
implication 
Gene 
polymorphism 
DNA samples origin (n) Reference 
CYP8A1 
Ovary, heart, 
skeletal 
muscle, lung 
and prostate 
Pathogenesis of 
vascular diseases
9 VNTRs in the 5’-
proximal 
regulatory region 
of the CYP8A1 
gene 
European (78 French 
Caucasians); African (50 
Gabonese and 50 
Tunisians) 
[38] 
CYP2A13 
Lung tissue 
 
Susceptibility of 
tobacco-related 
tumorigenesis 
3 SNPs: 578C>T 
(exon 2), 3375C>T 
(exon 5) and 
720C>G (3’UTR) 
European (52 French 
Caucasians); African (36 
Gabonese and 48 
Tunisians) 
[39] 
CYP3A5 
Liver 
Metabolism of 
chemotherapeutic 
agents and toxins
17 SNPs on the 13 
exons of the 
CYP3A5 gene 
European (51 French 
Caucasians); African (36 
Gabonese and 36 
Tunisians) 
[41] 
CYP2F1 
Lung tissue 
Metabolism of 
pneumotoxicants 
with carcinogenic 
effects 
Frameshift 
mutation in 
CYP2F1 exon 2 
(c.14_15insC) 
European (90 French 
Caucasians); African (32 
Gabonese, 37 Tunisians 
and 75 Senegalese) 
[40] 
CYP4A11 
Liver and 
kidney 
Regulation of 
blood pressure in 
the kidney 
1 SNP on 
CYP4A22-exon 11: 
8590T>C 
European (99 French 
Caucasians); African (36 
Gabonese, 53 Tunisians 
and 50 Senegalese); South 
American (60 Peruvians) 
[42] 
VNTR: variable number of tandem repeats; SNP: single nucleotide polymorphism; 3’UTR: 3’ 
untranslated region 
Table 2. Genetic polymorphisms in enzymes of the cytochrome P450 superfamily (CYP), in 
diverse populations including Gabonese 
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population groups (Tunisians, Gabonese, and Senegalese) presented a higher IMPDH2 activity 
than Caucasians, with implications for the dose requirement of IMPDH2 inhibitors 
administered to patients [43]. 
This compilation of genetic data on populations from Central Africa is far from being 
exhaustive. As an example, the genetic polymorphism of Toll-Like Receptors (TLR) is to 
date extensively explored in order to deepen the understanding of the first steps of the 
immune recognition. Also, cytokines that regulate adaptive immune responses (humoral 
immunity and cell-mediated immunity) may present inter-individual genetic variations 
such as it is the case for IL-2, IL-4, IL-5, IFN-gamma, TGF-beta, LT-alpha or IL-13. Finally, 
increasing information is generated every day thanks to equipments (such as real-time PCR 
systems or DNA sequencers) that allow handling simultaneously a great number of 
biological samples. Altogether, this review of genetic data gathered during the last twenty 
years among Central African populations, illustrates in which point Africa, which is thought to 
be the homeland of all modern humans, is the most genetically diverse region of the world. 
3. Animals 
Methods used to infer the respective role of historical, environmental and evolutionary 
processes on animal distribution are related to the molecular ecology field and, as such, very 
similar to those employed to study plant dynamic (see section 4.). For animal, sequence of 
genes of mitochondrial DNA (mtDNA) such as cytochrome b or control region genes are 
largely used in phylogenetic and phylogeographic studies. The evolutionary pace of 
mitochondrial genomes being relatively fast, mtDNA sequences can also be used in 
population genetics study even if nuclear markers (microsatellites, SNP, etc.) provide a 
higher level of information.  
3.1 Species identification from fecal pellets 
The inability to correctly identify species and determine their proportional abundance in the 
wild is of real conservation concern, not only for species management but also in the 
regulation of illegal trade. However, estimating species abundance using classical ecological 
methods based on direct observation is very challenging in Central Africa. Indirect methods 
based on animal tracks, especially fecal pellets have been proposed; however pellets of 
parapatric related species are sometimes very similar and difficult to use to reliably 
differentiate species in the field. To address this problem, a PCR-based method has been 
proposed to differentiate Central African artiodactyls species and especially duikers 
(Cephalophus) from their fecal pellets [44]. In this purpose, a mtDNA sequence database was 
compiled from all forest Cephalophus species and other similarly sized, sympatric 
Tragelaphus, Neotragus and Hyemoschus species. The tree-based approach proposed by the 
authors is reliable to recover most species identity from Central African duikers. 
3.2 Rivers are playing a major role in genetic differentiation for large primates in 
central Africa 
For both Gorillas (Gorilla gorilla; [45, 46]) and Mandrills (Mandrillus sphinx; [47]) 
phylogeographic studies based on mtDNA (for both species) and microsatellite (only for 
Gorilla) markers have shown that rivers hamper gene flow among populations and have a 
major role in partitioning the species diversity. For Mandrills, the Ogooué river (Gabon) 
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separates populations in Cameroon and northern Gabon from those in southern Gabon [47]. 
For Gorilla, rivers are more permeable and allow limited admixture among populations 
separated by waterways [45]. Anthony et al. also showed that like for plant species (see 
section 4) past vicariance events and Pleistocene refugia played an important role in shaping 
genetic diversity of current Gorilla populations [45]. 
3.3 Central African elephants: Forest or savannah elephants? 
Despite their morphology typical from forest elephants, a genetic study based on mtDNA 
[48] shows that Central African elephants are sharing their history with both forest and 
savannah elephants from Western Africa. It also gives evidence that Central African forest 
populations show lower genetic diversity than those in savannahs, and infers a recent 
population expansion. These results do not support the separation of African elephants into 
two evolutionary lineages (forest and savannah). The demographic history of African 
elephants seems more complex, with a combination of multiple refugial mitochondrial 
lineages and recurrent hybridization among them rendering a simple forest/savannah 
elephant split inapplicable to modern African elephant populations. 
4. Plants 
4.1 Methods and approaches 
This paragraph is giving on overview of approaches and methods related to the molecular 
ecology field and used to study natural or human-induced dynamic of plant species in Central 
Africa. Acknowledging the past history of the Central African forest domain is crucial for our 
understanding of spatial and temporal evolution of species living throughout the region.  
Historical processes responsible for the contemporary distributions of individuals can be 
studied within the field of historical biogeography or phylogeography. For phylogeographic 
studies the distribution of genetic lineages within or among closely related species is 
considered throughout the geographical space and current patterns are interpreted in light 
of past vicariance events, population bottleneck, survival in glacial refugia and/or 
colonization routes [49, 50, 51]. This approach can be combined with landscape genetic 
methods to respectively infer impact of historical and environmental processes on the 
distribution of the genetic diversity. Landscape genetic methods allow to correlate the 
distribution of the genetic diversity with environmental parameters and to reveal, for 
example, the impact of topographic features on gene flow or the role of soil heterogeneity in 
structuring the genetic diversity [52]. At finer scales, classical population genetic approaches 
address the role of additional evolutionary forces (drift, dispersal, mutation, mating system, 
etc.) in shaping current patterns. All these genetic-based approaches belong to the molecular 
ecology field and are combined to address questions linked to the natural species dynamic 
or more importantly, questions linked to the survival of threatened species facing forest 
fragmentation, logging activities, etc.  
All these approaches primary necessitate analyses of the genetic diversity at individual 
level. In this purpose, various techniques based on PCR are used. Different genetic markers 
can be chosen based on their respective evolutionary properties. For analyses of large-scale 
patterns, sequences of cytoplasmic DNA (ctDNA) like chloroplastic DNA (cpDNA) for 
plants are chosen. Cytoplamic DNA are haploid, non-recombining (or recombination events 
are rare) and generally characterized by uniparental inheritance (chloroplasts are generally 
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maternally inherited for angiosperm, paternally for gymnosperm plant species). These 
markers allow inference in genealogical histories of individuals, populations and/or species. 
It is however highly recommended to combine cytoplasmic with nuclear markers for 
intraspecific phylogeographic studies because of the uniparental inheritance of ctDNA. It is 
especially true for species with sex-biased dispersal capacities. For instance, cpDNA would 
show a very strong spatial structure for tree with heavy barochore (dispersed by gravity) 
seeds whereas nuclear genes dispersed by both seed and anemophilous (transported by wind) 
pollen, would not reveal any spatial structure. Therefore, sequences from nuclear genes could 
provide valuable information in phylogeographic assessments. They are nonetheless more 
complicated to analyze because of i) the difficulty to isolate haplotype from diploid organisms, 
ii) intragenic recombination and iii) the relatively slow pace of sequence evolution at most 
nuclear loci. Other nuclear PCR-based genetic markers such as microsatellites, AFLP 
(Amplified Fragment Length Polymorphism), RAPD (Random Amplification of Polymorphic 
DNA) or SNPs (described in section 2.4) are also used for phylogeographic studies, most of 
them being particularly valuable for population genetic studies.  
4.2 Importance of the past climatic changes in shaping pattern of genetic diversity in 
Central Africa 
The Lower Guinea forest domain (the Atlantic coastal forest distributed from Nigeria to 
Congo) has undergone major distribution range shifts during the Quaternary, but few 
studies have investigated their impact on the genetic diversity of plant species. Several 
phylogeographic studies using either cpDNA polymorphism [52, 53, 54, 55, 56, 57] and/or 
nuclear markers such as RAPD [58] and microsatellite markers [53, 59, 60] have recently 
been published, considering Central African trees as model species, to give insight into the 
historical biogeography of the region. For most of the studied species, the genetic diversity 
is very spatially structured throughout the species distribution giving strong 
phylogeographic signals. These results show that the Central African rainforest domain was 
very fragmented during the cool and dry periods from the Last Glacial Maximum period at 
the end of the Pleistocene (20000-13000 years before present) and more recently during the 
Little Ice Age (about 4000-2500 years before present). During these periods, most tree species 
and probably forest species in general, only survived in a reduced number of isolated 
populations in areas where environmental conditions remained suitable. The question is 
now to test for the presence of forest refugia in Central Africa, in other words: did forest-
species all survived in the same areas? In this case, effort for the conservation of these areas 
must be treated with the highest priority as refugia may play a major role in the survival of 
forest-species, while climate is changing, probably in buffering effect of the fluctuations.  
First results show that some refugia were shared among several tree species with one main 
refugium in the North and one in the South of the thermal equator (e.g. Milicia excelsa in [53], 
Erythrophleum suaveolens in [55], Irvingia gabonensis in [56], Distemonanthus benthamianus in [60]. 
Other species managed to survive in additional areas with at least four remaining populations 
for Aucoumea klaineana in Gabon [59]. More species covering all functional groups (pioneer, 
understorey, long-lived, etc.) must be studied to be able to infer general trends to allow 
predictions about impact of the Global Climate Change on species distribution. 
4.3 Importance of species life history traits in the maintenance of genetic diversity 
At finer scale, microsatellite loci were used to infer species dispersal ability of threatened 
tree species. Baillonella toxisperma Pierre Sapotaceae is a very low-density tree. The species is 
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insect-pollinated and its seeds are dispersed by animals, including elephants. Using spatial 
genetic structure analyses, Ndiade-Bourobou et al. were able to demonstrate that dispersal 
distances were uncommonly high and able to connect trees present in very low density 
throughout forest [61]. This process allows the maintenance of high genetic diversity in 
reducing inbreeding effect and assures as such the survival of the species. This equilibrium 
is very vulnerable as both tree and animal-vectors densities have dramatically dropped due 
to additional effects of logging, hunting and poaching activities. For Aucoumea klaineanea 
Pierre Burseraceae, a highly logged tree species in Gabon, Born et al. show that dispersal 
distance is very limited and that founder effects associated with colonization processes are 
avoided by the homogeneity in reproductive success in adults [62]. Their results also 
suggest [63] that reduced density of trees and/or forest opening is balanced by higher gene 
dispersal distances. This result is linked with dispersal syndromes of the species that locally 
contribute to the maintenance of the genetic diversity.  
5. Pathogens 
A lot of diseases of animal origin and their rapid spread and possible transmission to humans 
(HIV/AIDS, Ebola, Avian Influenza, etc.) can pose a threat to human health. Tools have 
evolved from simple serological screenings to specific amplification using conventional or Real 
Time PCR methods, hence allowing more suitable diagnostic methods for early stage detection, 
identification and characterization of emerging or re-emerging pathogens. We’ll successively 
take examples of pathogens infecting i) humans (parasites, viruses, bacteria, in section 5.1), non-
human primates and other animals (section 5.2), and finally pathogens of plants (section 5.3). 
5.1 Pathogens in humans 
5.1.1 Parasites 
Health in Central Africa is triggered by malaria, the most studied human parasite. Malaria 
transmission remains holoendemic in Central Africa in spite of decades of efforts in 
implementation/operational research. Other parasitic diseases are of utmost importance in 
term of public health, as human African trypanosomiasis (or sleeping sickness), filariasis, 
intestinal parasites, schistosomiasis, toxoplasmosis and amibiasis; however, they are all 
considered as neglected diseases. The PCR techniques contribute to the diagnostic of these 
infections. These techniques also improve our understanding of the physiopathology of 
these diseases through basic research. PCR indubitably helps to diagnose more efficiently 
and to find new therapeutic strategies. 
5.1.1.1 PCR and diagnostic for human parasites in Central Africa 
The Table 3 shows a few examples of PCR-based diagnostics for human parasites, although 
these techniques are not the gold standard for diagnosis of human parasites. The high cost 
of the PCR-based techniques is mainly mentioned as inconvenient. New diagnostic 
techniques should be implemented once it’s demonstrated that the balance cost/benefit is 
lower than 1. First, the technique must be feasible in routine laboratories in terms of 
equipment and training of local agents. Secondly, the new technique has to offer a benefit in 
terms of clinical treatment of the patients. This clinical benefit may result in a better 
specificity and sensitivity, and in a reduced time to diagnosis. The improvement of 
sensitivity allows the detection of sub-microscopic infections, as detailed in the chapter of 
this book titled “Submicroscopic infections of human parasitic diseases” by Touré-Ndouo. 
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The main advantages of diagnosis by PCR for human parasites from Central Africa are both 
the higher specificity and the small amounts of blood or tissue required. The specificity of 
DNA sequences offers a simple tool to distinguish species. As an example, the species 
spectrum of intestinal parasites involved in hospitalized AIDS patients was determined in 
the Democratic Republic of the Congo [64]. Opportunistic infections were detected by PCR, 
as Cryptosporidium sp., Enterocytozoon bieneusi, Isospora belli and Encephalitozoon intestinalis. 
The other intestinal parasites detected by PCR were Entamoeba histolytica, Entamoeba dispar, 
Ascoris lumbricoides, Giardia intestinalis, hookworm, Trichiuris trichiura, Enterobius 
vermicularis, and Schistosoma mansoni. Furthermore, the PCR-based diagnostic is quite more 
sensitive than microscopic examination, which is sometimes not sufficient to differentiate 
various parasite species. This is clearly the case for filariasis [65] and schistosomiasis [66]. In 
human sleeping sickness, PCR on blood allows avoiding painful lumbar punctures and was 
proposed as a less-invasive alternative to replace the cerebrospinal fluid examination. 
However, in this case, PCR is a good tool for primodiagnostic but cannot be used for post-
treatment follow-up. Indeed, the high sensitivity of PCR leads to detection of persisting 
DNA in blood of patients even after successful treatment [67]. 
 
 Se.* Spe.* Advantage Inconvenient Ref. technique Reference 
Plasmodium spp 
(qPCR)§ 
99.40% 90.90% 
Limit of 
detection 
greatly 
reduced 
High cost 
Microscopy 
examination of 
thick and thin 
blood smears 
[70] 
T. brucei 
gambiense in 
blood by PCR 
88.40% 99.20% Non invasive 
Not suitable 
for follow-up 
Microscopic 
analysis of the 
CSF 
[67] 
L. loa, M. 
perstans and W. 
bancrofti by 
nested PCR 
100%$ 100%$ 
High se. and 
spe. for 3 
filariosis co-
endemic 
Cost 
Knott’s 
concentration 
and microscopic 
examination 
[65] 
S. mansoni  in 
fecal samples 
by qPCR 
86.50% 100% 
High spe. to 
distinguish 
species 
High cost; 
Not intended 
for routine 
diagnostic 
Microscopic 
examination of 
Kato 
[66] 
S. haematobium 
in fecal samples 
by qPCR 
82.80% 100% 
Microscopic 
examination of 
filtrated urine 
samples 
* Se. sensitivity, Spe. Specificity, CSF cerebrospinal fluid 
§ qPCR, quantitative polymerase chain reaction 
$ 30% of samples not done by PCR 
Table 3. Efficiency and characteristics of PCR-based diagnostic in several endemic human 
parasitosis that are prevalent in Central Africa 
Malaria constitutes one of the major public health problems in Central Africa. As Plasmodium 
falciparum infection is deadly when untreated in children and pregnant women, its diagnostic 
has to be accurate and fast. At hospital level, where many malaria diagnostics are performed a 
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day, cost/benefit may be convincing and PCR-based diagnostic may be implemented. 
However, the benefits linked to PCR-based diagnosis for malaria are the identification of the 
different Plasmodium species and a lower detection limit. This is not necessarily clinically 
relevant. In addition, the existence of alternative diagnostic techniques as rapid diagnostic tests 
(RDTs) based on immunochromatographic assays to detect specific Plasmodium antigens that 
are recommended by the WHO, increases the cost/benefit ratio for PCR [68, 69]. 
Finally, PCR-based diagnosis is a very good tool for epidemiological survey. It still needs 
improvement in terms of cost, feasibility and quickness to deserve an implementation in 
Central African routine laboratories. 
5.1.1.2 PCR and research on human parasites in Central Africa 
As malaria is the most prevalent infection in Central Africa with the higher mortality 
incidence, this part will focus on malaria. The aim of this part is to point out the central role 
of PCR techniques in malaria research performed in Central Africa, without providing an 
exhausting list of its applications. The Figure 1 summarizes the research applications in the 
malaria field related to PCR-based techniques. 
Fundamental research 
The link between fundamental and operational research is tight, particularly for pathologies 
like malaria that need field studies to confirm hypotheses. Molecular epidemiology for 
malaria parasite is an example of this tight link. The study of SNPs related to drug resistance 
in P. falciparum on a genome-wide scale in a diversity of strains from Africa provides 
information on the frequency of the studied SNPs. If drug resistance requires several SNPs 
and those naturally occurring SNPs are rare in most genes, it may last years for the parasite 
to acquire a drug resistant phenotype. So, it is important to know whether P. falciparum 
genome presents low or high level of SNPs in endemic areas. However, the generation of 
new P. falciparum variants encoding for different levels of SNPs can result of tandem repeats 
of similar sequences (called RATs) that could undergo slip-strand mispairing. Replication 
slippage or deletion mechanisms lead to the apparition or lost of different RATs. 
Interestingly, the high frequency of RATs close to drug resistance or immune response 
target sequences can result in a fast increase of important SNPs (reviewed in [71]).  
The development of new diagnostics for malaria is also dependant of PCR-based techniques. 
The first RDTs for malaria were supplied more than 15 years ago. Some of them are based 
on immunochromatographic detection of P. falciparum histidine-rich protein 2 (PfHRP2), 
using monoclonal antibodies. PfHRP2 is an abundant circulating protein easily detectable in 
the blood of patients. However, some studies reported variable test performances. In that 
way, complementary studies were necessary to compare the PfHRP2 sequences from several 
parasite strains and the potential consequences on the performance of PfHR2-based RDTs. 
The genetic diversity of the pfhrp2 gene was studied in isolates originating from 19 countries 
including Central African countries and the relationship between the pfhrp2 diversities and 
the sensitivities of PfHRP2-based RDTs was assessed [72]. The results indicated that 2 types 
of repeats in the DNA sequence of PfHRP2 were predictive of RDT detection sensitivity 
with 87.5% accuracy. These results pointed out the importance of the genetic background of 
the parasites and their diversity in the different geographic endemic areas. 
Parasite antigen diversity studies at the molecular level are also performed for vaccine 
research. P. falciparum erythrocyte membrane protein 1 (PfEMP1) is a major vaccine target as 
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evidence supports the central role of PfEMP1 in the development of a protective acquired 
immunity in children and pregnant women living in high level endemic areas. However, 
PfEMP1 undergoes a serious problem. PfEMP1 is highly polymorphic and encoded by a 
gene family of 50-60 var genes. To identify specific var genes or domain structuring these 
genes and related to protective immunity, many molecular studies were done and are still 
currently performed, all based on the basic molecular technique, PCR. In pregnancy-
associated malaria, some studies showed that the var gene expressed called var2csa is 
relatively conserved. A comparative study showed that Duffy binding–like domains from 
placental parasites from Gabon and Cameroon shared 85%–99% amino-acid identities, 
confirming the conserved nature of placental variants [73]. This demonstration of sequence 
conservation in PfEMP1 DNA and its implication in the binding to chondroitin sulfate A 
(CSA) and to the pathology was clearly relevant to vaccine development for pregnancy-
associated malaria. Today, it is largely recognized that the parasite ligand mediating CSA 
binding and causing malaria in pregnancy is VAR2CSA, a member of PfEMP1 family, and 
that it is a promising target for vaccine design. Recent researches focus on the molecular 
variability of var2csa in field isolates and on the immune response induced by different 
domains of the protein. Vaccine research largely depends on immunological studies, as this 
is clearly the case with the example of PfEMP1. However, PCR is not the favorite technique 
for such studies unlike flow cytometry or Enzyme Linked Immunosorbent Assay (ELISA). 
For immunological topics related to malaria, PCR is mainly used in studies on human 
genetic markers linked to malaria protection (see section 2 of this chapter). 
Operational research 
The evaluation of the therapeutic and control strategies implemented to fight against 
malaria constitutes operational research. First, PCR has become an essential technique for 
the evaluation of antimalarial treatment efficiency. Historically, in vivo resistance of P. 
falciparum to antimalarial drugs was classified into three grades, RI (low), RII (intermediate), 
and RIII (high) [74]. Since 2002, therapeutic failures are divided in early and late treatment 
failures (ETF, LTF), and LTF includes late clinical failures and late parasitological failures 
[75]. Both classifications are based on follow-up studies of parasitemia in patients treated 
with antimalarial treatments. Usually, follow-ups last 28 days, but are now extended to 42 
days with the use of artemisinin-based treatment combinations (ACT) [75]. The classification 
relies on the reappearance or not of parasites during the follow-up. In highly endemic areas 
for malaria, the reappearance of parasites may be linked to the persistence of the initial 
infection, or to a new infection that occurred during the follow-up (the incubation time for 
P. falciparum is 7 to 10 days). A first study was performed in Central Africa in Gabon to 
demonstrate the great advantage of PCR to distinguish recrudescent P. falciparum clones 
from new ones, in studies of antimalarial treatment efficacy [76]. The technique involves 
amplification by PCR of regions of 3 highly polymorphic parasite genes, merozoïte surface 
protein-1 (msp-1), msp-2 and glutamate-rich protein (glurp). Through this study, the authors 
showed that 39% of RI resistant cases were in fact due to new infections. Today, PCR 
genotyping is systematically included in treatment efficacy studies [75]. 
The implementation of therapeutic strategies for malaria in a specific area has an impact on 
the deployment of parasite resistance to the drug used. It is of high importance to study the 
development of parasite resistance in malaria endemic areas, in order to suggest new 
policies once treatments become inefficient. PCR is definitely the basic tool to perform such 
studies once molecular mechanisms of resistance have been demonstrated through more 
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fundamental research. Sulfadoxine-pyrimethamine (SP) treatment has been used for a long 
time as second-line treatment for uncomplicated malaria in case of chloroquine treatment 
failure. The parasite mechanisms of resistance to SP have been well described and result in 
SNPs located on Pfdhfr and Pfdhps genes that appear in a few years following the 
implementation of such molecules. PCR followed by sequencing is the usual technique to 
study the rate of these mutations. In Gabon, Congo and Cameroon, the rate of Pfdhfr and 
Pfdhps mutations has been followed for years and constituted serious arguments to search 
other alternative treatments to chloroquine [77, 78, 79]. Since the era of ACT has begun, 
research teams based in Central Africa also use PCR-based techniques to follow the 
emergence of molecular markers related to the resistance to artemisinin-based molecules 
[80, 81]. 
Malaria prevention is also carried out through the use of insecticide treated materials or 
indoor residual spraying in Central Africa. This strategy has some implications on the spread 
of pyrethroid resistance in Anopheles gambiae and this has become a major concern in Africa. A 
PCR-RFLP assay was developed in Cameroon to follow two SNPs in the gene encoding 
subunit 2 of the sodium channel, also called the knockdown (kdr) mutations [82]. Since that 
time, studies to follow the situation of insecticide resistance are performed. In Gabon, both 
kdr-e and kdr-w alleles were shown to be present at high frequency in the Anopheles gambiae 
population. Of course, these results have implications for the effectiveness of the current 
vector control programmes that are based on pyrethroid-impregnated bed nets [83]. 
 
Fig. 1. The use of PCR-based techniques in the malaria field for operational and 
fundamental research 
5.1.2 Viruses 
This part will describe how the PCR-based techniques have been applied to many viruses 
infecting humans living in Central Africa, such as Human Immunodeficiency Virus (HIV), 
Human T cell Leukemia Virus (HTLV), Influenza virus, Hepatitis virus, and Ebola virus, for 
their origin, circulation, diversity, diagnosis, surveillance, and/or monitoring. Table 4 gives 
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several examples of pathogens infecting humans in Central Africa, which have benefited 
from PCR technologies, with a particular emphasis on viruses. 
5.1.2.1 Human Immunodeficiency Virus (HIV) 
Central Africa has been described as the “epicenter of the HIV pandemic”[84]. Scores of 
articles have used PCR methods to report findings related to the viral diversity of HIV in 
this region, emergence of new strains [85] and recombinant forms [86], emergence of 
resistance to antiretroviral drugs [87], and challenges encountered for the genotyping tests 
because of the broad diversity of HIV strains [88]. In this section we’ll explain the usefulness 
of PCR in i) the identification of various HIV strains found in Central Africa, ii) the early 
diagnosis of HIV, especially in exposed infants, iii) the management of infected patients, iv) 
implementation research and finally, we’ll underline the need of an African AIDS vaccine. 
PCR has help in the discovery and description of the virus  
Since the discovery of HIV in the early 80s by Montagnier and Gallo, many strains, types, 
subtypes, circulating recombinant forms (CRFs) and unique recombinant forms (URFs) have 
been described and characterized in patients from the Central African region. The discovery of 
new HIV variants occurred by atypical serological reaction, and confirmation was obtained 
by simple PCR, nested PCR, heteroduplex mobility assay (HMA) (see Box 1) or sequencing. 
Particularly, full-length genomes sequencing has been instrumental in the characterization of 
new HIV CRFs, such as HIV-1 CRF 25_cpx [89] and CRF 22_01A1 [86, 90] in Cameroon. 
Obviously, the characterization of all these variants has an impact on HIV diagnosis, treatment 
and vaccine development, especially for the HIV-infected individuals leaving in Central 
Africa. The genetic diversity of HIV-1 group M in the republic of Congo was described and 
documented [91]. This was achieved using specific PCR coupled to HMA techniques of the env 
and gag genes (see Box 1). In Equatorial Guinea, Hunt et al. described the variability of HIV-1 
group O, while Peeters et al. performed a wider study of HIV-1 group O distribution in Africa 
[92, 93, 94]. Although ELISA was mainly used in this latter study, indeterminate cases were 
solved using PCR. In Gabon, a great quantity of HIV strains collected from 1986 to 1994 was 
characterized by molecular biology techniques (PCR, sequencing); then phylogenetic trees 
were constructed [95]. A high prevalence of HIV-1 recombinant forms has been reported in 
Gabon [96]. In Cameroon, many studies have been carried out on genotyping subtypes of 
HIV-1 [86, 97, 98, 99]. Recently, new HIV-1 groups named group N and group P have been 
identified from Cameroonian patients [100, 101, 102, 103]. 
PCR is used routinely for the diagnosis of HIV  
Despite antibody testing being commonly used in HIV RDTs, this methodology is not 
suitable in children born of HIV seropositive mothers during the first 15 to 18 months of life. 
The reason is that maternal antibodies transferred to the infant during pregnancy or 
breastfeeding persist up to 18 months and could give false positive results. Therefore, 
detection of proviral DNA by PCR is recommended for the early diagnosis in HIV-exposed 
infants. Detection of HIV proviral DNA is performed using the Roche Amplicor HIV-1 DNA 
commercial test, which is so far considered as the gold standard. This test reveals an HIV-1 
infection within neonates and infants from 6 weeks of life and beyond. This test targets the 
gag gene during amplification where a fragment of 120bp is amplified and then, detection is 
based on ELISA. The kit is stored at 4°C and was especially designed for HIV-1 group M. 
Blood samples are collected as Dried Blood Spots (DBS), which have already been used for 
nationwide HIV prevalence survey in Africa [104]. More than 305,000 children in 34 
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countries worldwide have been offered early infant diagnosis (EID) and antiretroviral 
treatment thanks to the Clinton HIV/AIDS initiative (CHAI) and UNICEF, both managing 
the funds from UNITAID. The Amplicor HIV-1 DNA commercial test is currently used in 
several laboratories throughout Africa, and Cameroon is probably the leading country in 
Central Africa with a well-developed national EID programme, implemented by the 
Ministry of Public Health in the 10 regions of the country since 2007 [105]. 
PCR allows the management of HIV infection 
Two main tests employing PCR techniques are useful for the biological follow-up of HIV-1-
infected individuals i) the viral load (VL), which uses RNA PCR and ii) the resistance 
testing, which consists in amplification of specific viral fragments and sequencing. Viral 
load is mostly useful to follow the progression of the disease and for therapeutic monitoring 
as well. According to the commercial kits that are currently available, products of 
amplification can either be detected at the end of the reaction or while they accumulate in a 
real time manner. The lack of a commercially available viral load assay for HIV-2 is a 
concern for the proper management of patients infected with HIV-2 strains [106]. The 
resistance testing is actually an HIV-1 genotyping assay where the protease and the reverse 
transcriptase conserved regions of the pol gene are amplified and sequenced, as described by 
Fokam et al. [107]. Only two commercial tests approved by the Food and Drug 
Administration are currently available, and have been used widely to follow-up patients 
under antiretroviral treatment [108, 109, 110] and to report drug resistance mutations in 
HIV-1 reverse transcriptase or protease [109, 111, 112]. However, such commercial kits are 
very expensive for resource-limited countries like those of Central Africa and also their 
performance is questionable because of the great diversity of strains found in that region. 
For these reasons, an in-house genotyping assay has been developed in Cameroon recently 
and it is considered as more performant and cost effective than commercial kits [107]. 
 
Box 1. Heteroduplex Mobility Analysis  
The use of PCR in implementation research 
Implementation research is essential for the control of infectious diseases of poverty [113]. 
Although PCR technologies are sophisticated and require a certain level of technical 
The heteroduplex mobility analysis (HMA) is a molecular biology technique based on PCR 
amplification then followed by polyacrylamide gel electrophoresis analysis. This method 
has been first used for the subtype determination of HIV-1 group M envelope sequences, 
but has been recently developed for gag gene sequences. 
 
Principle of the HMA test: 
Heteroduplexes are formed with uncharacterized DNA fragments and known DNA 
sequences (as reference) included in the kit. Importantly, env gene fragments of 
uncharacterized DNA fragments are amplified by nested PCR whereas the reference 
sequences are obtained by direct amplification of plasmids from the kit. 
Mobility of such heteroduplexes is analyzed on polyacrylamide gels. The closest is the 
unknown DNA sequence with the reference sequence; the fastest is the mobility of the 
heteroduplex on the polyacrylamide gel. 
 
The HMA technique has been used to characterize HIV strains from Cameroon [1]. 
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expertise and facilities that are usually not available and not affordable in poor-resources 
settings, implementation research studies can help to find alternative solutions. For 
example, the fact that DBS can replace blood samples advantageously has been instrumental 
in increasing access to HIV diagnosis in exposed infants living in remote settings, through 
the implementation and scale-up of the EID program [105]. Equally, DBS can improve the 
biological follow-up of HIV-1-infected individuals, both for the VL quantification and the 
resistance testing. Indeed, DBS, which can be collected on sites, transported and tested after 
a long-term storage, are suitable for the differed quantification of HIV-1 RNA, thus allowing 
people living with HIV/AIDS in rural areas to have access to this sophisticated test [114]. 
On another hand, implementation of resistance testing on DBS is in progress in Africa [115, 
116] and will soon benefit HIV-1-infected patients living far from urban areas in Central 
Africa [108]. While waiting for the development of point of care assays, DBS appear to be a 
good alternative for the monitoring of HIV-1-infected people in remote settings (reviewed in 
[117]). However, the transport of samples and the return of results remains challenging, and 
need additional implementation research. 
Back to the sites 
Central Africa could be the ideal place where an AIDS vaccine could be designed, because of 
the great diversity of strains that are found in this region. However, when the scientific 
community is reflecting on how simian immunodeficiency virus infections hosted by 
African nonhuman primates could help in designing an AIDS vaccine for example, Central 
African scientists are absent [118]. This situation should change and African institutions, 
supported by their government, should advocate strongly for and invest in an African AIDS 
vaccine. To this end, the African AIDS Vaccine Partnership (AAVP) intends to promote 
cutting-edge research for the development of an African HIV vaccine [119]. In addition, the 
European Developing Clinical Trial Partnership (EDCTP) is supporting several African 
institutions from Gabon, Congo and Cameroon to build capacity for the conduct of future 
HIV/AIDS clinical trials [120] and is advocating for support from governments. 
5.1.2.2 Human T cell Lymphotropic Virus (HTLV) 
Central Africa is one of the few regions of the world where HTLV type 1 (HTLV-1) is highly 
endemic, as reviewed by Gessain & Mahieux [121]. Sequencing of HTLV-1 focuses on the 
gene env and the long terminal repeat fragments [122]. Molecular studies have 
demonstrated that the several molecular subtypes (genotypes) are related to the 
geographical origin and not to the disease. For example, while the subtype A is considered 
as cosmopolitan, the subtype B is mainly found in Central Africa (Democratic Republic of 
Congo, Gabon, and Cameroon). The subtype D has also been described in individuals from 
Cameroon, Gabon, Central African Republic, but less frequently than the subtype B, and 
more specifically in Pygmies. New subtypes (E and F) would be equally present in this 
region [121]. Interestingly, the first complete nucleotide sequence of HTLV type 2 (HTLV-2) 
has been obtained in a 44-year-old male living in a rural area of Gabon, by using nested PCR 
[123]. However, HTLV-2 does not seem to be as prevalent as HTLV-1 in this region since in 
a recent epidemiological survey performed on 907 pregnant women, only one case of HTLV-
2 was reported [122]. In Cameroon however, HTLV-2 seroprevalence was 2.5% in Bakola 
Pygmies, but no HTLV-2 infection was found in Bantus [124]. HTLV type 3 (HTLV-3) and 
HTLV type 4 (HTLV-4) have been recently identified in primate hunters in Central Africa. 
Real-time PCR quantitative assays have been developed in the USA and allow detecting as 
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few as 10 copies of HTLV-3 or HTLV-4 sequences of the gene pol in a small amount of DNA 
from human peripheral blood lymphocytes [125]. However, a new method using a single tube, 
multiplex, real time PCR has been developed at the Centre International de Recherches 
Médicales de Franceville (CIRMF), Gabon, which allows detecting HTLV-1, HTLV-2 and 
HTLV-3 simultaneously [126]. This new PCR-based technique could be of valuable use for 
epidemiological studies in countries where those viruses are prevalent. 
5.1.2.3 Influenza virus  
Despite influenza surveillance was increasing worldwide, developing countries in general and 
Central Africa in particular paid very little attention to the 2009 pandemic. Very recently 
however, samples from patients living with influenza-like illness in Yaounde, Cameroon were 
analyzed with various techniques including real time reverse transcription-polymerase chain 
reaction (RT-PCR) thus allowing the detection and subtyping of influenza A (H1N1 and 
H3N2) and B viruses from these patients [127]. Because of the H1N1 influenza A pandemic, 
Cameroon entered in a global surveillance network and received a laboratory equipped with a 
robust PCR platform for diagnosing influenza viruses in remote settings [128]. 
5.1.2.4 Hepatitis viruses 
Hepatitis B virus (HBV) and hepatitis C virus (HCV) are endemic in the Central African 
region. Since the last two decades, the use of PCR techniques and phylogenetic analysis has 
led to characterize the genotype distribution of HCV in this area. The RNA is amplified by 
RT-PCR and nested PCR and the primers commonly used are specific to the 5’UTR and 
NS5B regions. In Cameroon, genotypes 1 and 4 are the most prevalent, but highly 
heterogeneous, with 5 subtypes 1, 4 subtypes 4 and unclassified subtypes, while the 
genotype 2 prevalence is low, with homogeneous sequences [129, 130]. Further work has 
help to understand the history of the HCV epidemic in Cameroon, where mass therapeutic 
or vaccine campaigns would have contributed to the spread of this infection during the 
colonial era [131]. In Gabon and Central African Republic, the predominance of the 
heterogeneous genotype 4 has been reported [132, 133, 134]. Equally, few HBV genotype 
studies have been conducted Central Africa. Makuwa et al. reported the identification of 
HBV-A3 in rural Gabon [135], while this genotype is co-circulating with HBV-E among 
Pygmies in Cameroon [136]. More recently, a pilot study was conducted in the village of 
Dienga, Gabon (previously described in section 2.1) with the aim of looking at potential 
interactions between HBV, HCV and P. falciparum infections, which are all very prevalent in 
this region [137]. In this study, HCV chronic carrier were identified by ELISA and by 
qualitative RT-PCR amplification of the 5’ non coding region, and P. falciparum infection 
were assessed by microscopic examination and in case of negative result, by PCR targeting 
the gene encoding P. falciparum SSUrRNA, previously described by Snounou et al. [138]. 
Interestingly, these results showed that HCV infection may lead to slower emergence of P. 
falciparum in blood [137]. Other studies have demonstrated the usefulness of the PCR as a 
tool for the description of the molecular diversity of other less known/marginal viruses in 
this region, such as hepatitis delta virus in Cameroon [139] and in Gabon [140], or hepatitis 
GB-C/HG virus and TT virus in Gabon [141]. 
5.1.2.5 Ebola virus  
Since the first declaration of deaths due to Ebola virus in Zaïre in 1976, the Central African 
region has been particularly affected by repeated Ebola outbreaks, which affected 
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populations from Gabon and Republic of Congo in addition to the Democratic Republic of 
Congo. However, publications on the detection of Ebola virus in humans by molecular 
studies such as RT-PCR are scarce. The first reason is that infected patients have been 
reluctant to any type of invasive sampling method. The second is that for cultural reasons, 
families strongly refuse that researchers collect postmortem skin biopsies [142]. By 
analyzing few serum samples and less invasive specimens such as oral fluid samples, 
Formenty et al. could detect Ebola virus by RT-PCR and compare the two types of 
specimens [142]. This RT-PCR method has been developed, implemented and evaluated for 
diagnostics purposes at the CIRMF in Gabon, where a tremendous work is being done in the 
field of Ebola and other hemorrhagic fevers [143]. It is clear that the RT-PCR is the most 
appropriate tool not only to diagnose the infection in patients at a very early stage, but also 
to follow-up recovering patients [144]. Of note, studies were more easily carried out in 
animals, where important findings using PCR technologies were reported (see section 5.2).  
In conclusion to this section on viruses, it is important to mention that new random priming 
methods adapted from the sequence independent single primer amplification (SISPA) 
technology are now available, and could be used to sequence whole genomes of all sorts of 
(known or unknown) RNA and DNA viruses [145]. This methodology, together with 
molecular clock analyses are needed to better understand the origin, circulation and 
diversity of all the viruses present in Central African populations. 
5.1.3 Bacteria 
In a review on the molecular epidemiology of bacterial infections in sub-Saharan infections, 
almost no information is reported from Central Africa [156]. Recently, molecular 
epidemiology methods have been applied to the genetic typing of Mycobacterium tuberculosis 
complex strains, the etiologic agents of tuberculosis, whose incidence is increasing 
dramatically in sub-Saharan Africa [157]. In 1993, a novel typing method called 
spoligotyping has been described [158]. This PCR-based method uses the DNA 
polymorphism of M. tuberculosis complex strains to detect and differentiate clinical isolates 
simultaneously, and allows their genotypic classification [159]. Briefly, this method aims at 
analyzing the so called DVR regions, which is composed of direct repeat (DR) regions, in 
which variable repeat sequences are inserted [160]. Spoligotyping, which is frequently 
compared to the conventional and more powerful RFLP method, remains a useful tool for 
genotyping clinical isolates in various epidemiological settings. In Cameroon, Niobe-
Eyangoh et al. have used spoligotyping for analysis of hundreds of M. tuberculosis complex 
isolates from patients living in the West region [155]. This technique, which is considered as 
rapid, simple, and cost-effective, has been found accurate and easy to implement in that 
country, where the distribution of M. tuberculosis complex strains remains however still 
poorly documented, as well as the rest of Central Africa (see Table 4). 
5.2 Pathogens in animals 
Non-human primates from Central Africa have been extensively studied because it has 
been found that they are naturally infected with viruses or parasites similar to those 
affecting humans. The fact that humans are living in permanent contact with wild animals 
through hunting and butchering can explain transmission of pathogens from animals to 
humans. 
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5.2.1 Pathogens in non-human primates 
A substantial proportion of wild-living primates in Central Africa are naturally infected 
with Simian Immunodeficiency Viruses (SIVs) [161, 162, 163], Simian T-cell Lymphotropic 
Viruses (STLVs) [164, 165, 166, 167], Simian Foamy Viruses (SFV) [168] and also Hepatitis B 
Viruses (HBV) [169]. 
SIVs are lentiviruses that are found naturally in a great variety of nonhuman primates from 
Equatorial Africa, including but no restricted to chimpanzees (SIVcpz), mandrills, (SIVmnd-
1 and SIVmnd-2), drills (SIVdrl), talapoin monkeys (SIVtal), sun tailed monkeys (SIVsun), 
African green monkeys (SIVagm), red-capped mangabeys (SIVrcm) (see [162, 163, 170] and 
[171] for review). The evolutionary origins of these related viruses have been studied by 
amplification of the gag, pol, and env genes, and by construction and analysis of evolutionary 
trees. Sequence analysis of the entire genome and phylogenetic analyses have led to the 
identification of distinct primate lentivirus lineages in which most of the SIV strains 
described so far can be classified (see [171] and Table 5). The example of SIVs illustrates how 
the PCR techniques have been instrumental in the characterization of new strains of 
pathogens in non-human primates of Central Africa. As previously mentioned for animals 
(see section 3) phylogeographic studies have been equally carried out for pathogens. In 
mandrills for example, the two types of viruses appear to be geographically distributed, 
since SIVmnd-1 was found in mandrills from central and southern Gabon whereas SIVmnd-
2 was identified in northern and western Gabon, as well as in Cameroon [163]. 
Other examples of pathogens in non-human primates from Central Africa could have been 
used, like the STLVs (the simian counterpart of HTLVs), the SFVs and/or HBV, which 
similarly to SIVs have been described and characterized with molecular techniques 
including PCR. With no pretention of being exhaustive, the Table 5 summarizes several 
examples of pathogens found in animals from this region, with the technique used, the gene 
amplified, and appropriate references for more details. Of note, molecular techniques 
adapted to non-invasive fecal samples have been pivotal to identify simian viruses in quite a 
number of species, especially in case of wild living primates. 
These findings from Central Africa on pathogens in non-human primates together with 
those reported in humans, give a more comprehensive picture of the relationship between 
simian viruses and their counterpart in humans. 
Indeed, the use of PCR related technologies and the clustering of sequences has helped to 
understand that i) cross species transmission of viruses (from non-human primates to 
humans) occurred in Central Africa through highly exposed population such as hunters and 
people handling primates as bush meat [164] and ii) species barriers could be easier to cross 
over than geographic barriers [165]. Taken together, these observations reveal that the risk 
of emergence of new viral diseases in Central Africa is still latent. 
Similarly, various species of Plasmodium, including P. falciparum have been found in great 
apes (chimpanzees and gorillas) in Central Africa [172, 173]. If blood samples are not 
suitable for systematical analyses in primates, especially in case of wild primates; the 
identification of Plasmodium by PCR has been facilitated by the use of fecal primate samples, 
which are also broadly collected for the identification of simian viruses (see above). The 
identification of new species of Plasmodium, such as P. gaboni, which infects chimpanzees 
and P. GorA and P. GorB, which infect gorillas, has help to obtain a more comprehensive 
view of the phylogenetic relationships among Plasmodium species [173].  
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By sequencing the complete mitochondrial gene or at least a part of the cytochrome b, and 
Bayesian or maximum-likelihood methods, phylogenetic analyses can be performed, hence 
allowing a better understanding of the origins and evolution of malaria parasites and 
possibly transmission between apes and humans [172]. 
5.2.2 Pathogens in other animal species 
Apart from non-human primates, other animals from the Central African region have been 
studied for their possible implication in the life cycle of viruses causing hemorrhagic fever 
like Ebola or Marburg, which are both affecting great apes and humans. For example, 
sequences of Ebola were detected by PCR in small rodents and shrews, suggesting that 
common terrestrial small mammals living in peripheral forest areas may play a role in the 
life cycle of the Ebola virus [174]. More recently, Ebola and Marburg viruses were found in 
symptomless infected fruit bats in Central Africa, indicating that these animals could 
therefore act as the natural reservoir of these both viruses [153, 175]. 
In the context of outbreaks of highly pathogenic avian influenza, ducks from the far north 
region of Cameroon were found to host a highly pathogenic avian influenza subtype H5N1, 
whose sequence was closely related to H5N1 isolates reported in other African countries [176]. 
5.3 Pathogens in plants 
For plant pathogen, PCR-based techniques are essentially used in two purposes: i) to 
identify pathogen species, comparing pathogen sequences to known pathogen sequence 
libraries or ii) to characterize pathogen colonization dynamic. One example of each 
application is summarized below. 
5.3.1 Which fungi are attacking Central African Terminalia species? 
Begoude et al. collected fungal inoculum on Terminalia in Cameroon to identify which 
pathogens are threatening these highly logged tree species. They compared DNA sequence 
for the ITS and tef 1-alpha gene regions to known pathogen libraries and showed that the 
majority of isolates are from the Lasiodiplodia genus [186]. 
5.3.2 The colonization dynamic of Mycosphaerella fijiensis in Cameroon 
Dispersal processes of fungal plant pathogens can be inferred from analyses of spatial 
genetic structures resulting from recent range expansions. The fungus Mycosphaerella 
fijiensis, pathogenic on banana, is an example of a recent worldwide epidemic and is 
currently threatening Cameroonian banana plantations. Halkett et al. collected fungal 
isolates in Cameroon and analyzed them using 19 microsatellite markers. They 
demonstrated that large gene flows are linking populations even separated by long 
distances, through dense banana plantations, and so ensuring stable demographic regime 
and promoting efficient colonization dynamic of the fungus [187]. 
6. Opportunities and challenges 
Some of the few research institutes and molecular biology laboratories that have been 
mainly involved in the findings reported above are the CIRMF (Franceville, Gabon), which 
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is equipped with BSL3 and BSL4 facility, and the CIRCB (Yaounde, Cameroon), among 
others. Despite the amount of work and publications that have been generated from the 
Central African region, institutions and scientists involved in molecular biology research in 
Central Africa are facing several problems including procurement, maintenance, human 
resources, capacity building and ethics–related issues. 
Obtaining the valuable results depends on multiple factors including methodology of 
sampling, processing, storage and shipment of samples to laboratory with respect of 
maintain of the cold chain. As described above, problems related to sampling were well 
circumvented with animals. Indeed, by using shed hair or feces, which are non invasive 
methods of sampling, phylogenetic analyses have allowed a better understanding of the 
evolutionary history of gorillas [46] mandrills [47] or elephants [48]. Equally, a number of 
simian viruses have been characterized in fecal samples, which is more convenient, 
especially in case of wild-living primates. In these contexts, new reagents such as the RNA 
later® have been very helpful to stabilize and protect RNA in fresh collected specimens, 
hence allowing an extended period of storage before processing the samples. In humans, the 
collection of samples via DBS is simple, convenient, and cost effective. Transportation does 
not require any cold chain, and storage is easier than samples obtained from whole blood. In 
the field of HIV, DBS are advantageous for the biological follow-up of infected patients 
living in remote areas [117]. 
Another issue, which has to be taken into consideration, is related to the issue of the quality 
control and quality assurance, which need permanent improvement and capacity building 
efforts. Due to limited resources and equipment, and possibly because the culture of 
research is still dramatically lacking in most of sub-Saharan African countries [188], only 
few laboratories have obtained certification and the roadmap to accreditation is still far 
ahead. Therefore there is an urgent need that institutions from Central Africa participate 
more in laboratory accreditation programs, with the goal of seeking lab accreditation and 
excellence in general. For example, the World Health Organization (WHO)-AFRO and the 
Center for Disease Control Global AIDS program have launched recently an accreditation 
program for quality improvement of African laboratories for HIV monitoring. However, 
such programs will also improve the monitoring of HIV-TB coinfected patients, and by 
extension, the follow-up of patients suffering from other diseases, such as malaria or any 
neglected disease. Equally, support from the EDCTP is currently helping African 
institutions -grouped in regional Networks of Excellence- to conduct future clinical trials in 
the four regions of sub-Saharan Africa. To achieve this goal, a lot of efforts have been put 
into building capacity of young African scientists and laboratories, which have to meet 
international standards and respect good clinical and laboratory practices [120]. 
Studies reported here have been carried out mainly in the framework of collaborative 
research with institutions from the North. However, DNA samples are often kept abroad, 
with the partners, without any signed material transfer agreement. In some other cases, 
African scientists and institutions from the region are not associated to the work and/or 
publications. The researcher’s community has to be aware of avoiding the “banking” of 
DNA from African populations outside from Africa, mutualising benefits with the 
concerned populations and scientific partners as well as respecting ethical issues, such as 
establishing a fair partnership between African scientists and scientist from the North. The 
lack of these aspects have been demonstrated in a recent bibliometric review on human 
genetic studies performed during the two last decades in Cameroon [189]. Recently, the 
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African Society of Human Genetics launched the Human Heredity and Health in Africa 
(H3Africa) initiative, with the support of the National Institutes of Health and the Wellcome 
Trust (see http://h3africa.org/). The aim of this initiative, which was first discussed at the 
Yaoundé meeting in March 2009, is to conduct genomics-based research projects in Africa in 
order to better understand health and diseases in various African populations and to 
identify possible populations that are at risk of developing a specific disease. To this end, 
various calls for proposals have been launched, in which African institutions will take the 
leading role. One of these calls is the H3 Africa biorepository grant, which will address the 
need of biobanking samples in Africa for Africa. This H3Africa programme gives a lot of 
hope that capacity building and ethics-related will be soon addressed in favor of African 
institutions and African scientists and other scientists living in Africa, and that partnerships 
will eventually result in true win-win collaborations. 
7. Conclusion   
The contribution of PCR technologies to humans, animals, plants and pathogens from 
Central Africa is considerable, hence allowing the discovery of new species of plants and 
pathogens in this region, particularly in Gabon (see http://www.cirmf.org/en/publications). 
The richness of animals, plants, and pathogens is unquestionable and the Central African 
region is notorious for its great biodiversity. 
In this chapter, a great number of PCR-based techniques have been described, including but 
not limited to PCR-restriction fragment length polymorphism, PCR using sequence-specific 
oligonucleotide probes, combination of sequence-specific PCR and sequence-based typing 
also called Haplotype Specific Sequencing, PCR-single strand conformational 
polymorphism, reverse transcriptase PCR, sequence independent single primer 
amplification technology, nested and semi-nested PCR, quantitative PCR, real time PCR, 
PCR multiplex, Heteroduplex Mobility Analysis, and spoligotyping. Applied to humans, 
these techniques have contributed significantly to increase the knowledge on human 
genetics, through immunogenetics and genetics epidemiology of infectious diseases. 
Particularly, a great number of molecular studies describe the genetic polymorphism of the 
various populations and ethnic groups living in this region (section 2). Applied to wild 
animals and non-invasive samples such as shed hair or feces, PCR technologies have for 
example facilitated the identification of related species, which are not easy to differentiate 
just by direct observation as done by ecologists, by using mitochondrial DNA (section 3). 
Applied to plants, PCR-based methods have contributed to a better understanding of spatial 
and temporal evolution of species found in that region, including colonization routes, and 
tree densities than can be modified because of activities of humans in that region (section 4). 
Finally, application of PCR technologies has been reported for pathogens infecting humans, 
animals and plants (section 5). Parasites, viruses, and bacteria that are prevalent in humans, 
non-human primates and other animal species, and fungal plant pathogens have been 
discovered and characterized through PCR-based techniques. 
The PCR-generated knowledge is benefiting to a broad range of disciplines, such as genetics, 
molecular ecology, phylogeography, botany, evolution, molecular epidemiology, and 
infectious diseases, amongst others. 
Altogether, these finding have contributed to a better understanding of the relationship 
between humans from Central Africa and their environment (animals, plants and 
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pathogens), and particularly the inter relationship between species. Indubitably, this will be 
of help for a better management of resources at the global level. In addition, progresses have 
been made in fundamental research, operational research, and research applied to 
diagnostics and monitoring of infected individuals. 
Challenges in conducting PCR-based research are procurement and storage of reagents and 
blood samples due to the cold chain, maintenance of equipment, as well as human 
resources, capacity-building and ethics-related issues. However, new initiatives such as 
those launched by the African Society of Human Genetics (H3 Africa), the AAVP 
(promoting an African AIDS Vaccine), and the EDCTP (supporting regional Networks of 
Excellence for the future conduct of clinical trials) are real opportunities for the scientific 
community that is working in Africa, to perform cutting-edge research where sophisticated 
molecular biology laboratories and bioinformatics platforms will be created/renovated and 
will complement each other. 
In conclusion, despite a challenging research environment and though the paucity of 
facilities, scientists from Central Africa have brought a significant contribution to the 
scientific community, through PCR-related technologies. Collaborative research with 
northern partners has been fruitful and must be always conducted while keeping in mind a 
fair partnership and authorship. PCR-based research is increasing significantly in Central 
Africa and must be recognized at the level of the scientific community. 
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